{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T09:06:53Z","timestamp":1784279213893,"version":"3.55.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,7,15]],"date-time":"2027-07-15T00:00:00Z","timestamp":1815609600000},"content-version":"am","delay-in-days":348,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100001006","name":"Breast Cancer Research Foundation","doi-asserted-by":"publisher","award":["BCRF-17-193"],"award-info":[{"award-number":["BCRF-17-193"]}],"id":[{"id":"10.13039\/100001006","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"NCI","doi-asserted-by":"publisher","award":["CA097397"],"award-info":[{"award-number":["CA097397"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"NCI","doi-asserted-by":"publisher","award":["CA206464"],"award-info":[{"award-number":["CA206464"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"NCI","doi-asserted-by":"publisher","award":["CA285801"],"award-info":[{"award-number":["CA285801"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"NCI","doi-asserted-by":"publisher","award":["CA008748"],"award-info":[{"award-number":["CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"NCI","doi-asserted-by":"publisher","award":["CA234752"],"award-info":[{"award-number":["CA234752"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"NCI","doi-asserted-by":"publisher","award":["CA129639"],"award-info":[{"award-number":["CA129639"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"NCI","doi-asserted-by":"publisher","award":["CA083178"],"award-info":[{"award-number":["CA083178"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ijrobp.2026.02.237","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T17:09:07Z","timestamp":1772125747000},"page":"1512-1521","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrating Genomic and Nongenomic Data to Stratify the Risk of Contralateral Breast Cancer After Radiation Therapy"],"prefix":"10.1016","volume":"125","author":[{"given":"Sangkyu","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andriy","family":"Derkach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne S.","family":"Reiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan","family":"Woods","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Concannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles F.","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen E.","family":"Malone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia A.","family":"Knight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther M.","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph O.","family":"Deasy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonine L.","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8791-2755","authenticated-orcid":false,"given":"Jung Hun","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2026.02.237_bib0001","series-title":"New malignancies among cancer survivors: SEER cancer registries, 1973-2000","author":"Curtis","year":"2006"},{"key":"10.1016\/j.ijrobp.2026.02.237_bib0002","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJM199203193261201","article-title":"Cancer in the contralateral breast after radiotherapy for breast cancer","volume":"326","author":"Jr","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2026.02.237_bib0003","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(08)60069-0","article-title":"Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: Patient-level meta-analysis of randomised trials","volume":"371","author":"Clarke","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2026.02.237_bib0004","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S1470-2045(10)70257-6","article-title":"Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial","volume":"11","author":"Cuzick","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.237_bib0005","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1158\/1055-9965.EPI-10-1016","article-title":"Risk of a second breast cancer associated with hormone-receptor and HER2\/neu status of the first breast cancer","volume":"20","author":"Bessonova","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ijrobp.2026.02.237_bib0006","doi-asserted-by":"crossref","first-page":"R199","DOI":"10.1186\/bcr771","article-title":"Study design: Evaluating gene-environment interactions in the etiology of breast cancer - the WECARE study","volume":"6","author":"Bernstein","year":"2004","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.ijrobp.2026.02.237_bib0007","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/jnci\/djq055","article-title":"Radiation exposure, the ATM Gene, and contralateral breast cancer in the Women's Environmental Cancer and Radiation Epidemiology Study","volume":"102","author":"Bernstein","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2026.02.237_bib0008","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1200\/JCO.2009.24.2495","article-title":"Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2","volume":"28","author":"Malone","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.237_bib0009","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1200\/JCO.2012.43.2013","article-title":"Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: A report from the Women's Environmental Cancer and Radiation Epidemiology Study","volume":"31","author":"Reiner","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.237_bib0010","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1200\/JCO.2017.77.3424","article-title":"Breast cancer family history and contralateral breast cancer risk in young women: An update from the Women's Environmental Cancer and Radiation Epidemiology Study","volume":"36","author":"Reiner","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.237_bib0011","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1093\/jnci\/djt095","article-title":"Cancer risks for BRCA1 and BRCA2 mutation carriers: Results from prospective analysis of EMBRACE","volume":"105","author":"Mavaddat","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2026.02.237_bib0012","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s10549-007-9543-6","article-title":"The spectrum of ATM missense variants and their contribution to contralateral breast cancer","volume":"107","author":"Broeks","year":"2008","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ijrobp.2026.02.237_bib0013","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1200\/JCO.22.01239","article-title":"Contralateral breast cancer risk among carriers of germline pathogenic variants in","volume":"41","author":"Yadav","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.237_bib0014","doi-asserted-by":"crossref","first-page":"4308","DOI":"10.1200\/JCO.2012.42.7336","article-title":"CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer","volume":"30","author":"Weischer","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.237_bib0015","doi-asserted-by":"crossref","first-page":"R26","DOI":"10.1186\/bcr1668","article-title":"Identification of women with an increased risk of developing radiation-induced breast cancer: a case only study","volume":"9","author":"Broeks","year":"2007","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.ijrobp.2026.02.237_bib0016","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.ajhg.2023.02.003","article-title":"The impact of coding germline variants on contralateral breast cancer risk and survival","volume":"110","author":"Morra","year":"2023","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ijrobp.2026.02.237_bib0017","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/humu.21604","article-title":"Variants in activators and downstream targets of ATM, radiation exposure, and contralateral breast cancer risk in the WECARE study","volume":"33","author":"Brooks","year":"2012","journal-title":"Human Mutat"},{"key":"10.1016\/j.ijrobp.2026.02.237_bib0018","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13058-024-01765-1","article-title":"A genome-wide association study of contralateral breast cancer in the Women's Environmental Cancer and Radiation Epidemiology Study","volume":"26","author":"Sun","year":"2024","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.ijrobp.2026.02.237_bib0019","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.ijrobp.2021.01.045","article-title":"ATM variants in breast cancer: Implications for breast radiation therapy treatment recommendations","volume":"110","author":"McDuff","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.02.237_bib0020","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.prro.2016.10.012","article-title":"Likelihood of unacceptable normal tissue doses in breast cancer patients undergoing regional nodal irradiation in routine clinical practice","volume":"7","author":"Bazan","year":"2017","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.237_bib0021","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s10549-016-4039-x","article-title":"A model for individualized risk prediction of contralateral breast cancer","volume":"161","author":"Chowdhury","year":"2017","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ijrobp.2026.02.237_bib0022","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s10549-018-4763-5","article-title":"Validation of a personalized risk prediction model for contralateral breast cancer","volume":"170","author":"Chowdhury","year":"2018","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ijrobp.2026.02.237_bib0023","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s13058-019-1221-1","article-title":"Prediction and clinical utility of a contralateral breast cancer risk model","volume":"21","author":"Giardiello","year":"2019","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.ijrobp.2026.02.237_bib0024","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13058-022-01567-3","article-title":"PredictCBC-2.0: A contralateral breast cancer risk prediction model developed and validated in \u223c\u2009200,000 patients","volume":"24","author":"Giardiello","year":"2022","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.ijrobp.2026.02.237_bib0025","article-title":"Machine learning on genome-wide association studies to predict the risk of radiation-associated contralateral breast cancer in the WECARE Study","volume":"15","author":"Lee","year":"2020","journal-title":"PLOS One"},{"key":"10.1016\/j.ijrobp.2026.02.237_bib0026","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1186\/1471-2164-16-S2-S5","article-title":"Genome-wide association data classification and SNPs selection using two-stage quality-based Random Forests","volume":"16","author":"Nguyen","year":"2015","journal-title":"BMC Genom"},{"key":"10.1016\/j.ijrobp.2026.02.237_bib0027","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijrobp.2018.01.054","article-title":"Machine learning on a genome-wide association study to predict late genitourinary toxicity after prostate radiation therapy","volume":"101","author":"Lee","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.02.237_bib0028","article-title":"Computational methods using genome-wide association studies to predict radiotherapy complications and to identify correlative molecular processes","volume":"7","author":"Oh","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijrobp.2026.02.237_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109723","article-title":"Predicting the germline dependence of hematuria risk in prostate cancer radiotherapy patients","volume":"185","author":"Oh","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.237_bib0030","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-2105-9-14","article-title":"Allowing for mandatory covariates in boosting estimation of sparse high-dimensional survival models","volume":"9","author":"Binder","year":"2008","journal-title":"BMC Bioinform"},{"key":"10.1016\/j.ijrobp.2026.02.237_bib0031","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/bib\/bbq085","article-title":"Added predictive value of high-throughput molecular data to clinical data and its validation","volume":"12","author":"Boulesteix","year":"2011","journal-title":"Brief Bioinform"},{"key":"10.1016\/j.ijrobp.2026.02.237_bib0032","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1080\/00949655.2012.741599","article-title":"Mixed-effects random forest for clustered data","volume":"84","author":"Hajjem","year":"2014","journal-title":"J Statist Comput Simul"},{"key":"10.1016\/j.ijrobp.2026.02.237_bib0033","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1198\/106186006X133933","article-title":"Unbiased recursive partitioning: A conditional inference framework","volume":"15","author":"Hothorn","year":"2006","journal-title":"J Computat Graphical Stat"},{"key":"10.1016\/j.ijrobp.2026.02.237_bib0034","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/bioinformatics\/btp101","article-title":"ClueGO: A Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks","volume":"25","author":"Bindea","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ijrobp.2026.02.237_bib0035","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13058-016-0726-0","article-title":"Systemic therapy for breast cancer and risk of subsequent contralateral breast cancer in the WECARE Study","volume":"18","author":"Langballe","year":"2016","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.ijrobp.2026.02.237_bib0036","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/jnci\/87.9.645","article-title":"Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. Stockholm Breast Cancer Study Group","volume":"87","author":"Rutqvist","year":"1995","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2026.02.237_bib0037","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0140-6736(05)66544-0","article-title":"Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials","volume":"365","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2026.02.237_bib0038","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.577420","article-title":"Alterations of lipid metabolism in cancer: Implications in prognosis and treatment","volume":"10","author":"Fern\u00e1ndez","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.237_bib0039","doi-asserted-by":"crossref","first-page":"29487","DOI":"10.18632\/oncotarget.15494","article-title":"Fatty acid metabolism in breast cancer subtypes","volume":"8","author":"Monaco","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijrobp.2026.02.237_bib0040","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s12079-018-0490-2","article-title":"Role of PI3K\/Akt on migration and invasion of MCF10A cells treated with extracellular vesicles from MDA-MB-231 cells stimulated with linoleic acid","volume":"13","author":"Leal-Orta","year":"2019","journal-title":"J Cell Commun Signal"},{"key":"10.1016\/j.ijrobp.2026.02.237_bib0041","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1186\/s12885-018-4757-z","article-title":"Association of tamoxifen resistance and lipid reprogramming in breast cancer","volume":"18","author":"Hultsch","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ijrobp.2026.02.237_bib0042","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1158\/1078-0432.CCR-03-0461","article-title":"Expression of the forkhead transcription factor FOXP1 is associated with estrogen receptor alpha and improved survival in primary human breast carcinomas","volume":"10","author":"Fox","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2026.02.237_bib0043","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s12672-011-0082-6","article-title":"FOXP1, an estrogen-inducible transcription factor, modulates cell proliferation in breast cancer cells and 5-year recurrence-free survival of patients with tamoxifen-treated breast cancer","volume":"2","author":"Shigekawa","year":"2011","journal-title":"Horm Cancer"},{"key":"10.1016\/j.ijrobp.2026.02.237_bib0044","first-page":"825","article-title":"Dysregulation of fatty acid metabolism in breast cancer and its targeted therapy","volume":"16","author":"Chang","year":"2024","journal-title":"Breast Cancer (Dove Med Press)"},{"key":"10.1016\/j.ijrobp.2026.02.237_bib0045","first-page":"1","article-title":"Tamoxifen in early-stage estrogen receptor-positive breast cancer: overview of clinical use and molecular biomarkers for patient selection","volume":"4","author":"Criscitiello","year":"2010","journal-title":"Onco Targets Ther"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301626004268?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301626004268?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T08:24:37Z","timestamp":1784276677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301626004268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0360301626004268"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2026.02.237","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrating Genomic and Nongenomic Data to Stratify the Risk of Contralateral Breast Cancer After Radiation Therapy","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2026.02.237","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}